追加説明:
Regulatory filings include US-DMF, CEP, and J-DMF/C-DMF (under submission or approval). C2 Pharma supplies a wide range of APIs and complex chemical compounds of synthetic and natural origin, including tropicamide, applied as a 0.5% or 1% topical ophthalmic solution on the cornea to induce mydriasis (pupil dilation) and cycloplegia (paralysis of the ciliary muscle) for diagnostic eye procedures.
評価とコメントを残す